NCT04948983 The Effect of a Patient Decision Aids for Breast Cancer Screening Status UNKNOWN Phase NA
NCT04948840 Pilot Study of the Predictive Value of TREM1 Expression and Activation in Inflammation and Radio-induced Mammary Fibrosis Status UNKNOWN Phase NA
NCT04947280 Single Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT04946864 A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer Status SUSPENDED Phase PHASE1/PHASE2
NCT04946227 Pembrolizumab and Paclitaxel in Hormone Receptor-positive, hyperMUTATted Metastatic Breast Cancer Identified by Whole exOme sequeNcing ('MUTATION2') Status UNKNOWN Phase PHASE2
NCT04943497 A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia Status COMPLETED Phase N/A
NCT04941885 Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2+/HR+ Breast Cancer Status UNKNOWN Phase PHASE2
NCT04940026 Study to Determine Absorption, Metabolism, and Excretion of [14C]-SAR439859, and to Assess Absolute Oral Bioavailability of Amcenestrant (SAR439859), in Healthy Post-menopausal Women Status COMPLETED Phase PHASE1
NCT04938505 Assessment of Health Related Quality of Life in Women Who Underwent Breast Reconstruction After Radical Surgery Status UNKNOWN Phase N/A
NCT04937309 Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea Status UNKNOWN Phase NA
NCT04936295 Fulvestrant Plus Anlotinib in HR(+)/HER2(-) Metastatic Breast Cancer With FGFR Mutation Status UNKNOWN Phase PHASE2
NCT04936243 TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance) Status COMPLETED Phase NA
NCT04933266 Subpectoral Plexus Block With Multi-level TPVB for Surgical Anesthesia During Primary Breast Cancer Surgery Status RECRUITING Phase NA
NCT04932031 Risk Prediction of Taxane Chemotherapy-Induced Peripheral Neuropathy Status TERMINATED Phase N/A
NCT04929548 Exploratory Study of Neoadjuvant Treatment of HER2-positive Breast Cancer With Py in Combination With HP Status NOT_YET_RECRUITING Phase PHASE4
NCT04929197 Evaluation of the Feasibility of Developing Personalized Breast Cancer Radiotherapy Assistive Device With 3D Printing Status UNKNOWN Phase NA
NCT04929132 Added Value of Contrast-enhanced Ultrasound for BI RADS 4A Nodules Status UNKNOWN Phase N/A